ArticleAddiction (Abingdon, England)2026
Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series.
Article in Addiction (Abingdon, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- County by county estimation of possible deaths averted, infections averted, and cost savings of overdose prevention centers in the United States from July 2019-June 2025.The International journal on drug policy · 2026Article
- Response to Crockford et al.: Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series.Addiction (Abingdon, England) · 2026Article
- Healthcare utilization and mortality after overdose prevention site closure: A linked cohort analysis using segmented difference-in-differences time series.Addiction (Abingdon, England) · 2026Article
- Overdose prevention site closure: A reply to Day et al.Addiction (Abingdon, England) · 2026Article
- County by county estimation of possible deaths averted, infections averted, and cost savings of overdose prevention centers in the United States from July 2019-June 2025.medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsEvidence regarding the impacts of supervised drug consumption services (SDC) remains mixed, and few evaluations have used individual-level, linkable health data to examine service withdrawal. In September 2024, the Red Deer overdose prevention site (OPS) in Alberta, Canada, was scheduled for closure, with operations ceasing on 31 March 2025. This study examined: (1) changes in weekly opioid agonist therapy (OAT) dispensing among identifiable OPS clients associated with the closure announcement and subsequent service cessation; and (2) changes in acute healthcare utilization and mortality.
designRetrospective cohort study using linked provincial administrative health data from 30 June 2024 to 6 months after the Red Deer site closure (27 September 2025). A segmented difference-in-differences interrupted time-series (DID-ITS) design compared Red Deer OPS clients with clients from a continuously operating OPS in Lethbridge. Within-site interrupted time-series (ITS) models were applied for Red Deer-only analyses.
settingTwo provincially regulated OPS programs in Alberta, Canada. The Red Deer OPS closure was publicly announced on 24 September 2024 and implemented on 31 March 2025. The Lethbridge OPS remained operational throughout.
participantsOPS clients with a linked personal health number (PHN) and at least one consumption event at the Red Deer (n = 381) and Lethbridge sites (n = 300). MEASUREMENTS: Primary outcome: weekly proportion of clients receiving ≥1 OAT dispensing. SECONDARY OUTCOMES: weekly emergency department (ED) visits, inpatient (IP) admissions, suspected opioid-related emergency medical services (EMS) events and mortality.
findingsPrior to the closure announcement, baseline weekly OAT proportions were lower in Red Deer (9.9%) than in Lethbridge (12.0%), with broadly similar pre-announcement trends. After the closure, the proportion of clients on OAT in Red Deer exceeded those in Lethbridge (16.1% versus 14.4%, respectively; P < 0.021). After closure, there was no statistically significant difference in the number of ED visits or suspected opioid-related EMS events in both the Red Deer only ITS models or in the proportion of these outcomes in the DID-ITS model comparing Red Deer and Lethbridge. Mortality events were rare during the follow-up period, and no statistically detectable increase was observed over the available follow-up.
conclusionsThe announcement and subsequent closure of the Red Deer overdose prevention site in Alberta, Canada, were associated with increased opioid agonist therapy dispensing among identifiable site users. Short-term effects on acute healthcare utilization and mortality appear stable but remain inconclusive due to the limited 26-week follow-up period and low event counts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.